Modeling the determinants of attrition in a two-stage epilepsy prevalence survey in Nairobi using machine learning

Abstract

Background

Attrition is a challenge in parameter estimation in both longitudinal and multi-stage cross-sectional studies. Here, we examine utility of machine learning to predict attrition and identify associated factors in a two-stage population-based epilepsy prevalence study in Nairobi.

Methods

All individuals in the Nairobi Urban Health and Demographic Surveillance System (NUHDSS) (Korogocho and Viwandani) were screened for epilepsy in two stages. Attrition was defined as probable epilepsy cases identified at stage-I but who did not attend stage-II (neurologist assessment). Categorical variables were one-hot encoded, class imbalance was addressed using synthetic minority over-sampling technique (SMOTE) and numeric variables were scaled and centered. The dataset was split into training and testing sets (7:3 ratio), and seven machine learning models, including the ensemble Super Learner, were trained. Hyperparameters were tuned using 10-fold cross-validation, and model performance evaluated using metrics like Area under the curve (AUC), accuracy, Brier score and F1 score over 500 bootstrap samples of the test data.

Results

Random forest (AUC = 0.98, accuracy = 0.95, Brier score = 0.06, and F1 = 0.94), extreme gradient boost (XGB) (AUC = 0.96, accuracy = 0.91, Brier score = 0.08, F1 = 0.90) and support vector machine (SVM) (AUC = 0.93, accuracy = 0.93, Brier score = 0.07, F1 = 0.92) were the best performing models (base learners). Ensemble Super Learner had similarly high performance. Important predictors of attrition included proximity to industrial areas, male gender, employment, education, smaller households, and a history of complex partial seizures.

Conclusion

These findings can aid researchers plan targeted mobilization for scheduled clinical appointments to improve follow-up rates. These findings will inform development of a web-based algorithm to predict attrition risk and aid in targeted follow-up efforts in similar studies.